Intravitreal bevacizumab for posterior capsule neovascularization
SJO-Saudi Journal of Ophthalmology. 2010; 24 (2): 63-65
en Inglés
| IMEMR
| ID: emr-98430
ABSTRACT
We report a case of rapid regression of extensive posterior capsule neovascularization in a 67-year-old diabetic male patient, who developed posterior capsule opacity with neovascularization one year post cataract surgery, after a single injection of intravitreal bevacizumab [Avastin] followed by neodymiumYAG capsulotomy. Rapid regression of the posterior capsule neovascularization, and visual improvement was observed 9 days after the intervention. Posterior capsulotomy was performed successfully without bleeding. Prior to posterior capsulotomy, intravitreal bevacizumab can result in rapid and dramatic regression of posterior capsule neovascularization
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Resultado del Tratamiento
/
Inhibidores de la Angiogénesis
/
Factor A de Crecimiento Endotelial Vascular
/
Anticuerpos Monoclonales
Tipo de estudio:
Informe de Casos
Límite:
Anciano
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Saudi J. Ophthalmol.
Año:
2010
Similares
MEDLINE
...
LILACS
LIS